Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA-PCL-PDMAEMA triblock copolymers.
about
Nanocarrier-mediated co-delivery of chemotherapeutic drugs and gene agents for cancer treatmentMultifunctional Chitosan Magnetic-Graphene (CMG) Nanoparticles: a Theranostic Platform for Tumor-targeted Co-delivery of Drugs, Genes and MRI Contrast Agents.Use of Nanotechnology to Develop Multi-Drug Inhibitors For Cancer TherapyHydrolytic charge-reversal of PEGylated polyplexes enhances intracellular un-packaging and activity of siRNANanocarrier for poorly water-soluble anticancer drugs--barriers of translation and solutions.The effect of N/P ratio on the in vitro and in vivo interaction properties of PEGylated poly[2-(dimethylamino)ethyl methacrylate]-based siRNA complexes.Multi-layered nanoparticles for combination gene and drug delivery to tumors.Biocleavable Polycationic Micelles as Highly Efficient Gene Delivery Vectors.Effective non-viral delivery of siRNA to acute myeloid leukemia cells with lipid-substituted polyethyleniminesCo-delivery of doxorubicin and siRNA using octreotide-conjugated gold nanorods for targeted neuroendocrine cancer therapy.Amphiphilic and biodegradable methoxy polyethylene glycol-block-(polycaprolactone-graft-poly(2-(dimethylamino)ethyl methacrylate)) as an effective gene carrier.Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.Pentablock copolymers of pluronic F127 and modified poly(2-dimethyl amino)ethyl methacrylate for internalization mechanism and gene transfection studies.Reconstitutable charged polymeric (PLGA)(2)-b-PEI micelles for gene therapeutics deliveryPharmacokinetic and tissue distribution of paclitaxel in rabbits assayed by LC-UV after intravenous administration of its novel liposomal formulation.Reversal of multidrug resistance in MCF-7/Adr cells by codelivery of doxorubicin and BCL2 siRNA using a folic acid-conjugated polyethylenimine hydroxypropyl-β-cyclodextrin nanocarrierDiblock copolymers with tunable pH transitions for gene delivery.Multifunctional nanocapsules for simultaneous encapsulation of hydrophilic and hydrophobic compounds and on-demand releaseOne-pot Synthesis of Functional Poly(amino ester sulfide)s and Utility in Delivering pDNA and siRNATargeted delivery of chemically modified anti-miR-221 to hepatocellular carcinoma with negatively charged liposomes.Co-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance.Combination drug delivery approaches in metastatic breast cancerInfluence of nano-carrier architecture on in vitro siRNA delivery performance and in vivo biodistribution: polyplexes vs micelleplexes.Enhanced apoptosis of ovarian cancer cells via nanocarrier-mediated codelivery of siRNA and doxorubicin.Advanced materials and processing for drug delivery: the past and the future.Novel polymer micelle mediated co-delivery of doxorubicin and P-glycoprotein siRNA for reversal of multidrug resistance and synergistic tumor therapy.Effective combination treatment of lung cancer cells by single vehicular delivery of siRNA and different anticancer drugs.Drug delivery systems for differential release in combination therapy.Self-assembled and nanostructured siRNA delivery systems.Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms.Copolymers: efficient carriers for intelligent nanoparticulate drug targeting and gene therapy.Application of living free radical polymerization for nucleic acid delivery.Pharmacogenomics-based RNA interference nanodelivery: focus on solid malignant tumors.Cationic polymers and their therapeutic potential.Polymer nanoparticulate drug delivery and combination cancer therapy.Recent advances in delivery of drug-nucleic acid combinations for cancer treatmentNanoparticle systems as tools to improve drug delivery and therapeutic efficacy.Materials innovation for co-delivery of diverse therapeutic cargos.DMAEM-based cationic polymers as novel carriers for DNA delivery into cells.Nanocarriers for delivery of siRNA and co-delivery of siRNA and other therapeutic agents.
P2860
Q26866566-7EFE6A7C-8A74-426D-A063-57321F349110Q33678931-1DD15220-032A-43D0-9126-54398B4AB86BQ33859472-B3AAB308-4782-42AA-961F-9297738DF045Q33918054-54951825-8138-48B4-AAED-89ED99A79D23Q33962553-AD391EC8-C5B6-4885-8B10-170FFC398557Q33999411-97B2860E-FCDD-4A4E-8D1C-14ED8928F39AQ34135640-6F459341-BE51-4CA8-90FB-AE659D43BE2EQ34242870-DD720BDA-2DC3-4782-8054-70E34C099CF0Q34406423-1C259834-0EB2-4529-A3AA-BCC6ED41736BQ34446374-485A40AE-4DB7-4213-AD9F-D932AD04E534Q34591849-02AD5B9C-3E21-4C2B-B000-A33183734911Q34622662-6D2B5C55-A30F-43CA-AEED-72CFBDAC2C71Q34762408-54900C00-6ABC-4AFC-A609-A45276B0F788Q34778155-61808CBE-AD7A-4BD5-B0B5-A27D388A0E24Q34871917-2EFEB647-7C26-4CAE-AE5C-86EA0388B2DEQ35546832-ACB543F1-35BF-4A52-AC50-1E0A65ABE92CQ35698421-04C7FD31-8D45-48FC-9FF5-35F1EDA73367Q35857162-DEF6BBF4-F079-44E1-8441-6B7DB2CE6996Q35883670-E5A4572D-3128-49C1-B99D-FC41B3BD83BDQ35914942-7F5A284A-6A7F-44EB-8434-E784C7167040Q35924301-7C624FAF-8269-4EAC-A2E9-8A7B9C0F3E4BQ35955198-5103EF35-7D67-407F-B055-292F319C46A5Q36052917-2F58F79E-136B-47FA-860B-CD7535CCA6F8Q36148627-0E1144BF-BAC0-4A5E-8699-A2271CC8D99EQ36589333-E79485D1-C0B0-4607-AFF0-EF83F8AA9FEFQ36748360-B20C7C71-F5C4-4216-8903-7D8E4F99B59EQ37265705-126092A0-F800-49CD-8543-246AFCC84288Q37827881-0CC6AD99-FBE3-4900-83B2-414B8E104AE2Q37855596-1EB10AF1-E6C3-4590-87B4-456A6B026E10Q37938830-5F608CCE-2382-4C98-9DF7-CDF3E00F4467Q37946820-89986651-88C4-448F-A282-497194F6FA72Q37975522-F12A777F-1B20-4DB6-97CD-11BF8714BA47Q38015528-2674660C-EBEF-4B7D-AD8E-9C008AD9EAE8Q38033969-C9BFCA8C-39FC-449B-A0C2-A81A77E9B03BQ38059506-37A70E25-0A8D-46AA-B838-FF0D68EFE24BQ38102522-3F57A3C8-867E-474B-B7D2-7B043DFA27ACQ38123458-9BD75DDA-6E95-48B9-A95A-18E5226AEEB9Q38211033-CB2E50DE-8EC1-41B9-9E36-1F5705B4E764Q38252406-1401BB1E-EEF2-41E1-BDF4-7699DC377971Q38555082-17092514-4EEB-4FE8-8729-5F162092E8B5
P2860
Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA-PCL-PDMAEMA triblock copolymers.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Co-delivery of siRNA and pacli ...... L-PDMAEMA triblock copolymers.
@ast
Co-delivery of siRNA and pacli ...... L-PDMAEMA triblock copolymers.
@en
type
label
Co-delivery of siRNA and pacli ...... L-PDMAEMA triblock copolymers.
@ast
Co-delivery of siRNA and pacli ...... L-PDMAEMA triblock copolymers.
@en
prefLabel
Co-delivery of siRNA and pacli ...... L-PDMAEMA triblock copolymers.
@ast
Co-delivery of siRNA and pacli ...... L-PDMAEMA triblock copolymers.
@en
P2093
P1433
P1476
Co-delivery of siRNA and pacli ...... L-PDMAEMA triblock copolymers.
@en
P2093
Caihong Zhu
Fenghua Meng
Sooyeon Jung
Tae Gwan Park
Xiulin Zhu
Zhiyuan Zhong
P304
P356
10.1016/J.BIOMATERIALS.2009.11.077
P577
2009-12-05T00:00:00Z